Physician

Santosh M Nair, MD

According to 2025 Medicare claims, Santosh Nair, MD (NPI: 1982653713) practices hematology/oncology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Volusia, FL. This provider's primary affiliated billing organization is MID-FLORIDA CANCER CENTERS LLC (NPI: 1255369955; TIN: 592021436) and primary practice location at 32763-8316.

Nair's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 418 traditional Medicare patients, billed 126,227 HCPCS/CPT codes, and received $1,710,345 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 2,296 prescription claims across 292 beneficiaries totaling $5,897,122 in drug costs, led by Lenalidomide (Lenalidomide). 2021 DME data shows 20 claims. Open Payments data shows 228 records totaling $2,164,019. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,023,290 to $5,897,122. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,240 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	646	130,347	$1,364,182
2016	556	139,901	$1,699,249
2017	501	97,962	$1,528,398
2018	495	114,077	$1,501,478
2019	478	113,199	$1,547,916
2020	429	121,069	$1,479,663
2021	401	99,635	$1,452,834
2022	406	94,500	$1,406,267
2023	546	111,201	$1,687,695
2024	418	126,227	$1,710,345

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	253	1,540	$1,023,290
2016	252	1,417	$2,412,068
2017	261	1,843	$2,355,163
2018	243	1,753	$2,895,772
2019	274	1,741	$2,610,164
2020	260	1,605	$2,940,201
2021	275	1,639	$3,092,590
2022	260	1,604	$3,614,914
2023	294	2,016	$5,361,350
2024	292	2,296	$5,897,122

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	111	$31,510
2016	N/R	78	$24,816
2017	N/R	91	$25,117
2018	N/R	40	$731
2019	N/R	50	$4,485
2020	N/R	38	$3,279
2021	N/R	20	$2,173
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	259	598	$66
80053	Blood test, comprehensive group of blood chemicals	253	588	$10
36415	Insertion of needle into vein for collection of blood sample	270	769	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	287	1,002	$8
84100	Phosphate level	253	580	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	43	1,204	$622,352
Ibrance	Palbociclib	26	728	$401,174
Calquence	Acalabrutinib Maleate	20	600	$307,449
Sprycel	Dasatinib	17	510	$306,937
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	29	287	$306,440

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$19	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	227	$2,164,000	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Santosh M. Nair, MD?

Tedicare shows public-source Medicare data for Santosh M. Nair, MD (NPI 1982653713), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Santosh M. Nair, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Santosh M. Nair, MD?

Santosh M. Nair, MD is linked to MID-FLORIDA CANCER CENTERS LLC (billing NPI 1255369955) in the available physician profile data.

Does Santosh M. Nair, MD have Open Payments data?

Santosh M. Nair, MD has 228 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.